{"name":"Clarus Therapeutics, Inc.","slug":"clarus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"topical testosterone gel","genericName":"topical testosterone gel","slug":"topical-testosterone-gel","indication":"Testosterone replacement therapy in adult males with hypogonadism","status":"marketed"},{"name":"Axiron Testosterone Topical Solution","genericName":"Axiron Testosterone Topical Solution","slug":"axiron-testosterone-topical-solution","indication":"Testosterone replacement therapy in adult males with hypogonadism","status":"phase_3"},{"name":"Oral Testosterone Undecanoate","genericName":"Oral Testosterone Undecanoate","slug":"oral-testosterone-undecanoate","indication":"Testosterone replacement therapy in adult males with hypogonadism","status":"phase_3"}]}],"pipeline":[{"name":"topical testosterone gel","genericName":"topical testosterone gel","slug":"topical-testosterone-gel","phase":"marketed","mechanism":"Topical testosterone gel delivers testosterone through the skin to replace deficient hormone levels in hypogonadal men.","indications":["Testosterone replacement therapy in adult males with hypogonadism"],"catalyst":""},{"name":"Axiron Testosterone Topical Solution","genericName":"Axiron Testosterone Topical Solution","slug":"axiron-testosterone-topical-solution","phase":"phase_3","mechanism":"Axiron delivers testosterone transdermally to replace deficient testosterone levels in hypogonadal men.","indications":["Testosterone replacement therapy in adult males with hypogonadism"],"catalyst":""},{"name":"Oral Testosterone Undecanoate","genericName":"Oral Testosterone Undecanoate","slug":"oral-testosterone-undecanoate","phase":"phase_3","mechanism":"Oral testosterone undecanoate is a testosterone replacement therapy that restores physiological testosterone levels in hypogonadal men.","indications":["Testosterone replacement therapy in adult males with hypogonadism"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZ3JtZ1NSd2lzV3NKcVdzU3NMYy1hZDh3anB3VmgxRS04aEpBRlQwNjRDMF94QkoyZ3dBVnpURWI5aWlXSVZCMGhseDA4akhkeHNCaENHTkk0M3pqc2FlMlBzazFXVDhiLWdFMGk4dzJrUWgxYkNONC12UDdSUzRBZ0RyWkRET0k2YTJSTjVTTUwyY3A3TEp5dzNUX052c1YxRHVBSXd0aWpfUmlOQTNHY2J5dThGbjBRS01zZWpxdzUwelVhWmN0WWdyWjk2dGVBeGlUc2Ffb1h3eHlaelh5bWEtRHNVdktSUjNldU9n?oc=5","date":"2024-09-26","type":"pipeline","source":"PR Newswire","summary":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight - PR Newswire","headline":"Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPTkt2ZjhMYnBuN3RrcnNTZmVIMXp6TFVsR0E1N2hJMlFpWVpKTGxwblJTWFNYLXRtRk9WTFhjQ2tPdmlEbEUtdVJXQ0NEMlc4dGQzYXk4cjFJYmFVd21pcE83NWk1RGJTTGMzM1pCcjVGanktMWo1VEx5S2xhY3FubHBDMUMxZnc1QlFzbw?oc=5","date":"2024-09-24","type":"pipeline","source":"Crain's Chicago Business","summary":"Swedish pharma brings on Horizon execs to launch U.S. HQ in Chicago - Crain's Chicago Business","headline":"Swedish pharma brings on Horizon execs to launch U.S. HQ in Chicago - Crain's Chicago Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPWEpDSnZ0U0pVbU0xbHR3M2NIX3hnd0VZTmNJRjVKdmp3d2VILUhIZVZSRjBwZ3BMTUZRVGFTRHVYZndZZjJwYVF3RUZYcmRtY1U5UW9mQTVJZDF4U2dWakNoU0J0MXN6Tlp5TGtoUVJIbHhxbDcyNmpXT053a2N1T0laSnJMV2xBaUt5WkVHYmVhUktId2pUWENsX2t2SWpIV21idThlYkNoSHJzOUlNZTloOEJ4NTNGY0E?oc=5","date":"2023-01-09","type":"deal","source":"reuters.com","summary":"Focus: Private equity acquires a taste for drug development - reuters.com","headline":"Focus: Private equity acquires a taste for drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPZkJ4NVlNeGZ6LTdwNWlrdmpoTklaNUNiTlhBM3dISVFldkdQYXlNVW4wMTZoTkJ3WktUcWw2aF8xM2F1eG9xTmtnZTFyLWhtekVPekdLWUhBS2ZBcGhwVXhjNklBblZ0TWtBQmZyTW1raUswR0dLZlpOZk9VZkRhNHhUZVQ5aVRZSFBXeNIBVkFVX3lxTFBfRjM0OXZ6eERoUTh6QU1xR3FPaXRjQTR0eTNCa3BwNVp1aHhmZmJjME93OTZWZTJZTU9Pd0pNSldMT2ZjcFVCdDFqalhCcDRueFFkMy1R?oc=5","date":"2022-10-26","type":"pipeline","source":"Law360","summary":"Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale - Law360","headline":"Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxQb1lHQUpJdV9aT0phYXRZTGdENTZIeFBXMGdJd2pqS1ByYkdQQlE5N05lZnZibTJPV0hUc1ZZRmVzWUpDSFZJZTJBZThKT0pyUEptSVFpVXVSLTd1UFUtRGVNanVoZWxRWDBWa0RIc0hRVnJBR1kxejV5ZERLcEszNjEzNTgzeE5wQURJSF9icUVXaUpmVkJUaVUzNTI4emVoRTBxSzZWUEY0ZXJIQ0prNmp0dTRDVks2TFE2TGllQng0VkRrLThDaTNQdXhOS0ZfMzY3dkJzdUkxZmt6c283a1JsdlFPTFIySHZvZFZWWEI1U3dGMlpQRFZiN21kbW1qbHR3WnVzOVgybVVHTkhscUFZUHplX2s1ZW1BTWFLTm5pNE1uUWt2WURUX1g3Yy1YcHBv?oc=5","date":"2022-10-18","type":"pipeline","source":"globenewswire.com","summary":"Clarus Therapeutics Holdings, Inc. Announces Completion of - globenewswire.com","headline":"Clarus Therapeutics Holdings, Inc. Announces Completion of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNX05nWi12UnpLcGRzTGhGcXZmaTUtUEJoUHA0emRMSHFxZU9TVXFIY29rbEp4b3EtRGtqZ3ZNX0xuZDRhZmZyQWJlYndIMEtkX1JWSkJLRjRJYzJoY3BLa2VGbEVwWVYxUWU5Y0R4cXVRY3ExR3FWdVRBNHdaaDBsbzd2REpRcDI4cVRfay1BMGtBdTJDbERj?oc=5","date":"2022-04-28","type":"patent","source":"Yahoo Finance","summary":"Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate) - Yahoo Finance","headline":"Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxOdzR4Rmc1bk5rZVR3WlRTRmxjOExab0tHeER6U055cjJZZWZ2bEVzMmhvRXA0eFl0Q1RkQkRqR2lGT0h3bGJQNFYzNWt3NmFvX2NRZXpFU3FTbE5VXzhNMjk3TWlGdDU2VEpKZEFtbkRMbUxkanZIeFowLXd6V0xGZnptOW4xLUQ4WGlRLWVOZXdDT052U09WdEZNUklPaTVZLWxBeTBqWWs5YldKQUlTR2RNYW1sa3lsNDdmTzdQX01BZjFvWEdBWG1zVDJnZ3g0VkhEOWx1ejlNNlpQM3R2a1Q2TTIzWGNscUFLUHNHNnFMT0pBN1VaOFdoLTAzMkZlVU5iMWl4RzduMllpTlRkNTVGUU9TamtsMFk3N01ZQzIydm0yQlcycUE0UDdxcm5mY3k3XzZYSHVLWC16cnp2T0h1REp0Zm5MVGhHaTdHcmFIN19maS1R?oc=5","date":"2022-02-24","type":"deal","source":"globenewswire.com","summary":"Clarus Announces Strategic Partnerships for JATENZO® - globenewswire.com","headline":"Clarus Announces Strategic Partnerships for JATENZO®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPRGlTQlhwQksyN0dfVFFlU3FpYm9TV0xNSzlzc0QwbTgtTGdRb09nTTRsdzhfZmZEMzVjYzg2N3BDNkRCT0RFTi1PUHdYUUVHZHpqVUhtODc2R21WclNwdllaVXR3c0JNNGhrT1JjUE1sTlh4cTZEMUZucFVNaFJhWG1GcGtxRk56VWU5QnRhSm5UTl85NnpYSFBLVjlVd2hGZGRmYmRxVF9hSmdEMTVfRGRvTEVaTTVyUE1wMzhFR1VneWREd3VvZW1Vd2ZxVnpLd01QR0dSQlBoaHNNeHhqdDZtRWJtQW8?oc=5","date":"2021-10-27","type":"pipeline","source":"PR Newswire","summary":"Testosterone Replacement Therapy Market to Grow by USD 113.54 million from 2019 to 2024|Technavio - PR Newswire","headline":"Testosterone Replacement Therapy Market to Grow by USD 113.54 million from 2019 to 2024|Technavio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPX2ZUZkdBUzBIVWphbFdrdTZ6eE4zZUJiZE8tLVZZWDhlWVUyakZ4S3czNkZSVVo5TkFlUmtDcUtpOVFIVnRDVnJreFVrcVJuODdNU05Uai1hYjBmcXZLN3ZxS3B0dWlmNGVWN0hMbjNWOVl0NUpPTjZOTGh3SC1KUXhjb1MzSWlKRjBDa0NMelBNZ21NOVB6aFhhV3Z5R203OUMxT2Q4RnJLMVFpeF91UVNPWElqQUdpMDBsaTlyU2JaZkV3a2Z6YXJueWZIM1NKYzVUck1nYmF6UDg3c0d2UlVaY3JDd0E1ZnRyRmhIeVIyckRmMm1CVTJ1VWQ4dEtkdTZYc29vV1VFbUNLNkNUNTRZSFdNa2RXcU9VaWhocVZySzFEMXc?oc=5","date":"2021-05-25","type":"pipeline","source":"BioSpace","summary":"Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer - BioSpace","headline":"Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflamma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxQREJ0SXdMTU1CQzQ4MHdnYWc2Q2xzZnpsV3ZRS3dYYUo3elNDMVVicGtGdGxET091NXVmYk9NQnp2VExMYnlCUzRrUDJKQjB4aVBpWTVYUWZKRWJVbmk5MUtJQndFd19tQlByM090bWJ5eEFLMnhTWmg0Z1pTSjVwNDVvTTBZbGcydTZxU1hhSmVtWllySEZ0UjdxaEVuZWQ5cmhHZDYxLUc1Wk1TMmhKZW5Lb2JKNlBiZUtSUDl2eld2NU5JQWFOZDlpemNLb1N4UDA3RmFfVTh3alFiSVp0LWhfZ3JMelNNcGNSeVBNNGJRc3RBR3ZRVlNkN3VpcW1Ec012X2oxZ1A3cS16bVVnSGpjTlh3WTBHaWZkeWY0TFo?oc=5","date":"2021-03-20","type":"trial","source":"BioSpace","summary":"Clarus Therapeutics Presents Positive Safety And Efficacy Data For JATENZO® (Testosterone Undecanoate) Oral Capsules, CIII At ENDO 2021, The Endocrine Society's Annual Meeting - BioSpace","headline":"Clarus Therapeutics Presents Positive Safety And Efficacy Data For JATENZO® (Testosterone Undecanoate) Oral Capsules, CI","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQSm5ucHFMaHJsa3A4V2E1andpQ1B1RWJQdkZwRUhxU1d3WDNvVzZ4YTFQMmtoRF9mU0ozcmF6VWkyTVAwTm1YSnptSFhtNlFXY2RQZms0NG1Bczd2NVhzOFpieF91cmZ3MER0ZGsyV0tlRzlDcm14S0NVcldrTHZ2VS0wMWFBUG1ZbG5TVjhZQnh0cWhpb3N3?oc=5","date":"2019-03-29","type":"regulatory","source":"BioPharma Dive","summary":"Clarus picks up FDA OK for oral testosterone drug - BioPharma Dive","headline":"Clarus picks up FDA OK for oral testosterone drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wJBVV95cUxOZ1lETEFERGxoakdId3drVmgxMUxaTmFVNzFER0xOZURMT3pYVl9CMk9fMThtOXBQRXJ5MXpkLVBocDBsdGhRVi1RcG00a3EwekJmQmZBME4zWEtseDZPWkkyY1RIVFVhZ1NyUmcyTzVqZF9YWTNMT3RGQ0ZXSXNlOG5ySzJMX01MdWp4NEVUM2lIZVAzeUxmczBkUG5OcGVadzh5eFc2QlJwdFdTa29FRWY4SUhoOFRCbnFfbzBOcW42VkhiaXFjX3BtSElZNlU5aUlqdGpsS3Awb3FEd3hSZUljY1lXaE5OMHBZbldwWFpybjRENVJSMnNEa2QzTTN4VHVaNkRXZUNwak1uQnlHSUhTakZXNWVDa25kbUNxZ1hCQk5jQUdkSEdsVVhoeEdqZ3V0V3hwV2xNSEFKdjNOOGtDSEk0RExMU2gzcVQ2WEpMbk9LWlZoMXpoaUJ2OGs?oc=5","date":"2019-03-27","type":"regulatory","source":"globenewswire.com","summary":"Clarus Therapeutics Receives U.S. FDA Approval of JATENZO® - globenewswire.com","headline":"Clarus Therapeutics Receives U.S. FDA Approval of JATENZO®","sentiment":"positive"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}